Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nadalin

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Clinical Nutrition ESPEN|June 10, 2024
Indications and successes of intestinal transplantation in children in the 21st century: A retrospective cohort studyF Lacaille, E Ramos Boluda, G Gupte, et al.
Transplantation Proceedings|November 18, 2008
Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant: a center's experienceG C Sotiropoulos, H Lang, F H Saner, et al.
Transplantation Proceedings|November 18, 2008
Incidence of liver retransplantation and its effect on patient survivalH Lang, G C Sotiropoulos, S Beckebaum, et al.
European Journal of Medical Research|March 1, 2006
The "territorial belonging" of the middle hepatic vein: a troublesome dilemma in adult live donor liver transplantation--anatomical evidence based on virtual 3-dimensional-computed tomography-imaging reconstructionsA Radtke, T Schroeder, E P Molmenti, et al.
Transplantation Proceedings|November 18, 2008
Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experienceG C Sotiropoulos, G M Kaiser, H Lang, et al.
Scientific Reports|May 25, 2017
The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-AR Wagner, J Machann, M Guthoff, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 8, 2014
Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantationM Sterneck, G M Kaiser, N Heyne, et al.
Annals of Hematology|November 7, 2020
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registryMaria Madeleine Rüthrich, C Giessen-Jung, S Borgmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 16, 2023
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus StatementM Carbone, A Della Penna, C Mazzarelli, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 13, 2012
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECTL Fischer, J Klempnauer, S Beckebaum, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Clinical Nutrition ESPEN|June 10, 2024
Indications and successes of intestinal transplantation in children in the 21st century: A retrospective cohort studyF Lacaille, E Ramos Boluda, G Gupte, et al.
Transplantation Proceedings|November 18, 2008
Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant: a center's experienceG C Sotiropoulos, H Lang, F H Saner, et al.
Transplantation Proceedings|November 18, 2008
Incidence of liver retransplantation and its effect on patient survivalH Lang, G C Sotiropoulos, S Beckebaum, et al.
European Journal of Medical Research|March 1, 2006
The "territorial belonging" of the middle hepatic vein: a troublesome dilemma in adult live donor liver transplantation--anatomical evidence based on virtual 3-dimensional-computed tomography-imaging reconstructionsA Radtke, T Schroeder, E P Molmenti, et al.
Transplantation Proceedings|November 18, 2008
Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experienceG C Sotiropoulos, G M Kaiser, H Lang, et al.
Scientific Reports|May 25, 2017
The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-AR Wagner, J Machann, M Guthoff, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 8, 2014
Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantationM Sterneck, G M Kaiser, N Heyne, et al.
Annals of Hematology|November 7, 2020
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registryMaria Madeleine Rüthrich, C Giessen-Jung, S Borgmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 16, 2023
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus StatementM Carbone, A Della Penna, C Mazzarelli, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 13, 2012
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECTL Fischer, J Klempnauer, S Beckebaum, et al.
Pageof 9